Pink SheetThe European Medicines Agency has recommended that Gilead Sciences’ Yeytuo (lenacapavir), for preventing HIV, and 13 other new drugs should be granted pan-EU marketing authorization, but it has advise
In VivoKaren Rodriguez Lorenc’s journey from treating cancer patients in Argentina to leading Regeneron’s Hematology Oncology division exemplifies how clinical experience can transform pharmaceutical innovat
ScripApogee Therapeutics has posted positive data from its long-acting antibody, APG777, that showed it reduced symptoms of the inflammatory skin condition atopic dermatitis in a 123-patient Phase II study
ScripThe market for BCMA-directed therapies to treat multiple myeloma just got a little more crowded with the US Food and Drug Administration giving the green light to Regeneron Pharmaceuticals’ Lynozyfic